All Brands Owned by McKesson Corporation
McKesson Corporation owns 4 brands in our database. Browse the complete portfolio of McKesson Corporation subsidiaries and brands across various industries.
Company Type
public
Headquarters
Irving, Texas, USA
Brand Portfolio
4 brands
Stock
NYSE: MCK
Filter by Category
Showing Healthcare & Pharmaceuticals brands
4 of 4 total brands
Healthcare & Pharmaceuticals Brands
Biologics by McKesson
Owned by McKesson Corporation
Independent specialty pharmacy providing personalized patient care for oncology and rare disease treatments owned by McKesson Corporation.
Health Mart
Owned by McKesson Corporation
Independent pharmacy franchise network with over 4,500 member pharmacies across the United States owned by McKesson Corporation.
McKesson Medical-Surgical
Owned by McKesson Corporation
Medical supplies and equipment distribution brand providing healthcare products to physician offices, hospitals, and home health agencies owned by McKesson Corporation.
McKesson Provider Technologies
Owned by McKesson Corporation
Healthcare IT and software solutions provider offering electronic health records, pharmacy management systems, and clinical decision support owned by McKesson Corporation.
About McKesson Corporation
What does McKesson do?
McKesson distributes pharmaceutical products, including brand-name drugs, generic drugs, and specialty medications, to pharmacies, hospitals, physician offices, and other healthcare providers across the United States and Canada. The company also operates the US Oncology Network, distributes medical-surgical supplies, and provides technology solutions to biopharma manufacturers through its Prescription Technology Solutions segment.
Is McKesson publicly traded?
Yes, McKesson Corporation trades on the New York Stock Exchange under ticker symbol MCK. The company has no controlling shareholder, with ownership distributed among institutional investors including Vanguard Group and BlackRock.
What is McKesson's annual revenue?
In fiscal year 2024 (ended March 31, 2024), McKesson reported revenue of approximately $308.9 billion, a 10% increase from the prior fiscal year. The U.S. Pharmaceutical segment accounted for approximately $275 billion of total revenue.
Who is McKesson's CEO?
Brian Tyler has served as Chief Executive Officer of McKesson since April 2019, succeeding John Hammergren. Tyler has led the company's strategic focus on oncology and biopharma services as higher-growth businesses within the healthcare distribution ecosystem.
When was McKesson founded?
McKesson was founded in 1833 by John McKesson and Charles Olcott in New York City as Olcott & McKesson, making it one of the oldest continuously operating companies in the United States.
What is McKesson's role in the opioid settlement?
McKesson, along with Cencora and Cardinal Health, reached a $21 billion settlement with U.S. states and local governments in 2022 to resolve claims that the three distributors failed to adequately monitor suspicious opioid orders. McKesson's share of the settlement is approximately $7.9 billion, to be paid over 18 years.
Stock Information
Competitors to McKesson Corporation
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Takeda | Japan | 2011 | Mass Market | Asia Pacific | All Genders | |
| Novartis | Switzerland | 2009 | Mass Market | Global | All Genders |
Learn More About Competitors
Adcetris
Owned by Takeda Pharmaceutical Company
Prescription antibody-drug conjugate for treating Hodgkin lymphoma and other CD30-positive lymphomas, manufactured and marketed by Takeda Pharmaceutical Company.
Afinitor
Owned by Novartis
Prescription oncology medication for treating various cancers including renal cell carcinoma and breast cancer, manufactured and marketed by Novartis.
Competitive Analysis
Market Positioning: McKesson Corporation competes with 2 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
McKesson Corporation Brand Portfolio Overview
McKesson Corporation maintains a diverse portfolio of 4 brands across multiple industries. This comprehensive brand portfolio demonstrates the company's market presence and strategic business units.
Brand Portfolio by Industry:
- Healthcare & Pharmaceuticals: 4 brands
For consumers and researchers interested in corporate ownership structures, understanding which brands are owned by McKesson Corporationprovides valuable insights into market dynamics, product relationships, and corporate strategy.
Explore More
Jobs at McKesson Corporation
Latest News About McKesson Corporation
Articles About McKesson Corporation
View more articles
Monthly M&A Roundup: February 2026 Brand Ownership Changes
From Keurig Dr Pepper's planned split to the Netflix-WBD saga, here is every major brand ownership change and deal in February 2026.
The Most Acquired Categories: Tech vs CPG vs Pharma
Which industries see the most brand acquisitions? We compared technology, consumer goods, and pharmaceuticals to find out where the most M&A activity happens and why.
The Truth About 'Made in America' Brand Claims
Many brands market themselves as American-made. But what does that actually mean when the parent company is foreign, the parts come from overseas, and 'assembled in USA' is not the same as 'made in USA'?